APA (7th ed.) Citation

Lemech, C., Coward, J., Gao, B., Park, J., Zhou, C., Moore, M., . . . Yang, J. (2025). 1545P CS2009, a novel PD-1/VEGF/CTLA-4 trispecific antibody, in patients with advanced solid tumors: An open-label, multicenter, phase I first-in-human study. Annals of Oncology, 36, S923. https://doi.org/10.1016/j.annonc.2025.08.2176

Chicago Style (17th ed.) Citation

Lemech, C., et al. "1545P CS2009, a Novel PD-1/VEGF/CTLA-4 Trispecific Antibody, in Patients with Advanced Solid Tumors: An Open-label, Multicenter, Phase I First-in-human Study." Annals of Oncology 36 (2025): S923. https://doi.org/10.1016/j.annonc.2025.08.2176.

MLA (9th ed.) Citation

Lemech, C., et al. "1545P CS2009, a Novel PD-1/VEGF/CTLA-4 Trispecific Antibody, in Patients with Advanced Solid Tumors: An Open-label, Multicenter, Phase I First-in-human Study." Annals of Oncology, vol. 36, 2025, p. S923, https://doi.org/10.1016/j.annonc.2025.08.2176.